Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.
about
The epigenetic landscape of acute myeloid leukemiaThe emerging insights into catalytic or non-catalytic roles of TET proteins in tumors and neural developmentGenomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid LeukemiaConnections between TET proteins and aberrant DNA modification in cancerMyeloid malignancies: mutations, models and managementThe TET2 interactors and their links to hematological malignanciesTET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations.TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population.Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation.TET proteins and the control of cytosine demethylation in cancer.A zebrafish model of myelodysplastic syndrome produced through tet2 genomic editing.TET2 mutations in secondary acute myeloid leukemias: a French retrospective studyTET family proteins and their role in stem cell differentiation and transformation.TET family proteins: oxidation activity, interacting molecules, and functions in diseases.Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AMLTET2 Expression in Bone Marrow Mononuclear Cells of Patients with Myelodysplastic Syndromes and Its Clinical SignificancesHypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.Somatic alterations contributing to metastasis of a castration-resistant prostate cancerAlterations of 5-hydroxymethylcytosine in human cancers.Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significanceMolecular diagnosis of acute myeloid leukemia.Molecular biology of myelodysplastic syndromes.Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.Genetic biomarkers in acute myeloid leukemia: will the promise of improving treatment outcomes be realized?Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis.TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns.Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.TET2 Promoter DNA Methylation and Expression Analysis in Pediatric B-cell Acute Lymphoblastic Leukemia.Driver mutations of cancer epigenomes.Mutations in epigenetic modifiers in acute myeloid leukemia and their clinical utility.DNA methylation regulated gene expression in organ fibrosis.Prognostic value of brain and acute leukemia cytoplasmic gene expression in egyptian children with acute myeloid leukemia.Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium.Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.TET2 Inhibits Differentiation of Embryonic Stem Cells but Does Not Overcome Methylation-Induced Gene SilencingTET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations.Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype.Emerging molecular predictive and prognostic factors in acute myeloid leukemia.Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European population.
P2860
Q21284742-B18F389F-82BE-439C-B290-06DD70D0A373Q26739014-2A77B700-66B1-40DB-8A43-960A3828B7ADQ26796514-E54676E8-8047-421B-A60D-FE8FDBD31E70Q26865671-FFB6DFD3-971A-482F-8C37-A47FCD029082Q27000577-3A2484A1-EB7E-49B8-A998-D4747643C2D6Q27002485-BBE31047-3651-410C-A386-4D3076796865Q27851621-DC2EA4E1-6CB0-401A-A47B-C48BBF5D226AQ27853009-16C27456-F852-410B-BEF4-AAF67242866CQ33566938-9BF39380-B55A-4366-AFD4-717C7B118BD8Q33934784-A8262768-D1B1-4DDE-AA29-2BEB8F83EA1CQ35021377-6DCC3EEF-644F-4EFB-AF55-F0C6CC2AA8E2Q35069556-C7A5C75D-0384-4770-A142-951F0774368FQ35082536-5715C37A-A032-4635-B709-AD6D307BA1E7Q35630033-A4034638-24EF-4275-9769-02ECB4ED5028Q36668364-748BAF7B-3B9B-4492-8115-C986A2E071F9Q36797201-DE9D7318-BD3B-4A46-BF89-EC45B725FD58Q36814300-91B2A60A-AFFC-4258-A049-6C1E9C1F94D8Q36887700-AE843E2A-B513-4F7D-9AEA-6B351009FAD4Q37100131-42D1C8FD-A1D8-44B6-9CBE-0960DC49FAF2Q37226486-6B798DBC-11A9-4E22-A6B6-39E0C4CEF287Q37480308-7B494A66-3CB4-4F60-A25A-2E88EEB49449Q37809866-123B3E40-95BB-42E0-8D82-87AD74EC68FCQ37937809-D9472AD5-8866-4F20-BCB3-26F7EAAA785BQ37954583-7DE1C199-A5DA-4982-BE4B-A58D5956FCF0Q38044773-DF709BF5-B50C-427C-91AD-3F634FEB12BFQ38187680-498991B3-7C07-4A38-AFBF-2B835561490EQ38428907-797E4DFD-8A03-4D98-B783-F19B6896C6E2Q38509706-2C0DEBC2-DAC1-4D76-BE8F-D69FDCB490BAQ38628904-BA1D21AA-95EE-474E-9CFC-E3F73E4D62D5Q38639828-3F794242-7BE2-4AC2-9241-F73712A40780Q38703904-1DE4418A-FB75-47BD-A9D2-E9F103040CA9Q39304481-DCD57ACF-8994-46BE-8A72-6F86777771CEQ40219910-D42DD112-3B2B-409E-972C-981347E49A7BQ40298579-41550C23-3C1B-4431-BB32-97F204428A34Q41532867-15E0C2B7-CE19-47DB-B078-C0A490C792C2Q41787477-88B14B46-12CE-48DD-A755-31ED82EA83EDQ42416286-7FB3C9FD-4081-417A-8B20-8ED2558A107DQ42943348-2FE99A0F-7246-4696-8304-740223CD0AECQ47670541-D00A66BC-30F4-4B7F-B820-8B7D5BCD89C0Q50854174-F2D69E2B-4A78-44A6-941C-80B6BB221568
P2860
Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Incidence and prognostic value ...... achieving complete remission.
@en
type
label
Incidence and prognostic value ...... achieving complete remission.
@en
prefLabel
Incidence and prognostic value ...... achieving complete remission.
@en
P2093
P50
P1433
P1476
Incidence and prognostic value ...... a achieving complete remission
@en
P2093
Aline Renneville
Christophe Roumier
François Dreyfus
Hervé Dombret
Jean Soulier
Jean-Michel Cayuela
Nathalie Philippe
Nicolas Boissel
Pierre Fenaux
Samuel Quentin
P304
P356
10.1182/BLOOD-2009-07-234484
P407
P50
P577
2010-05-20T00:00:00Z